Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503607 · ClinicalTrials.gov registry record · Phase 3
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
- 11
- Study locations
NCT00503607: Completed Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
NCT00503607 is a Phase 3 study of Colonoscopy that has completed, run by Braintree Laboratories. The registered enrollment target is 400 participants, below the 482-participant average among 20 other Colonoscopy trials with a reported enrollment target (17% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00503607, a Phase 3 study of Colonoscopy, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Conditions Studied
Interventions
- DRUG BLI-800
- DRUG Polyethylene glycol 3350 based bowel preparation
Study Locations (11)
Florida
- - Jupiter
- - Miami
- - New Smyrna Beach
Alabama
- - Mobile
District of Columbia
- - Washington D.C.
Louisiana
- - Monroe
Maryland
- - Laurel
New York
- - Great Neck
North Carolina
- - Raleigh
Pennsylvania
- - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
What the finished NCT00503607 record still lists
NCT00503607 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 482-participant average among 20 other Colonoscopy trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which BLI-800 is the first listed.
NCT00503607 lists 11 locations in 9 states (Florida, Alabama, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT00503607 about?
NCT00503607 is a clinical study titled "BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00503607?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2007-07. Estimated completion is 2007-11.
What conditions does trial NCT00503607 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00503607?
The interventions under investigation include: BLI-800 (DRUG), Polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00503607?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00503607 being conducted?
This trial has 11 study locations across Alabama, District of Columbia, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00503607's enrollment target sits among peer trials
400 10th of 20 higher than 11 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
-
HalfLytely Bowel Prep System for Colonoscopy
COMPLETED · Phase 3
-
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
COMPLETED · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia